Overview

Update
Total Equity Funding
$284.36M in 10 Rounds from 25 Investors
Most Recent Funding
$12.37M Series D on February 22, 2016
Headquarters:
Redwood City, California
Description:
CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.
Founders:
Categories:
Pharmaceutical, Biotechnology, Health Diagnostics
Website:
http://www.cardiodx.com
Social:

Company Details

Update

CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.

Funding Rounds (10) - $284.36M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2016$12.37M / Series D0
Dec, 2014$35M / Series D1
Jul, 2014$20.98M / Private Equity1
Oct, 2012$6M / Private Equity4
Aug, 2012$58M / Private Equity11
Jul, 2012$30.51M / Private Equity14
Aug, 2011$8M / Series C4
May, 2011$60M / Private Equity13
May, 2010$34.5M / Series D8
Jul, 2006$19M / Series B3

Current Team (11)

Update

Offices/Locations (2)

Update
  • Office

    2500 Faber Place

    Palo Alto, CA 94303

    USA

  • CardioDx

    600 Saginaw Drive

    Redwood City, California 94063

    United States

Past Team (7)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos